T. Rowe Price Investment Management Inc. Sells 1,909,438 Shares of UnitedHealth Group Incorporated $UNH

Key Points

• T. Rowe Price Investment Management Inc. has reduced its stake in UnitedHealth Group by 39.9%, selling 1,909,438 shares, leaving it with 2,876,502 shares, which represents about 1.0% of its portfolio.
• CEO Patrick Hugh Conway sold 589 shares of UnitedHealth Group's stock for approximately $179,645, leading to a 5.36% decrease in his holdings.
• UnitedHealth Group's shares are down 1.5%, with recent earnings reporting an EPS of $4.08, missing the consensus estimate of $4.45.

T. Rowe Price Investment Management Inc. lessened its stake in UnitedHealth Group Incorporated (NYSE:UNH - Free Report) by 39.9% during the first quarter, according to its most recent filing with the Securities and Exchange Commission. The fund owned 2,876,502 shares of the healthcare conglomerate's stock after selling 1,909,438 shares during the period. UnitedHealth Group comprises about 1.0% of T. Rowe Price Investment Management Inc.'s portfolio, making the stock its 13th biggest position. T. Rowe Price Investment Management Inc. owned 0.32% of UnitedHealth Group worth $1,506,568,000 as of its most recent filing with the Securities and Exchange Commission.

A number of other institutional investors and hedge funds have also added to or reduced their stakes in UNH. Financial Management Professionals Inc. grew its stake in shares of UnitedHealth Group by 0.8% in the first quarter. Financial Management Professionals Inc. now owns 2,224 shares of the healthcare conglomerate's stock worth $1,165,000 after purchasing an additional 17 shares in the last quarter. Global Wealth Strategies & Associates lifted its stake in UnitedHealth Group by 28.6% in the 1st quarter. Global Wealth Strategies & Associates now owns 90 shares of the healthcare conglomerate's stock worth $47,000 after acquiring an additional 20 shares in the last quarter. Kolinsky Wealth Management LLC boosted its position in UnitedHealth Group by 1.0% during the fourth quarter. Kolinsky Wealth Management LLC now owns 2,135 shares of the healthcare conglomerate's stock valued at $1,080,000 after purchasing an additional 21 shares during the last quarter. Retirement Planning Group LLC boosted its holdings in UnitedHealth Group by 5.1% in the first quarter. Retirement Planning Group LLC now owns 430 shares of the healthcare conglomerate's stock worth $225,000 after purchasing an additional 21 shares in the last quarter. Finally, Net Worth Advisory Group lifted its stake in shares of UnitedHealth Group by 0.6% in the first quarter. Net Worth Advisory Group now owns 3,642 shares of the healthcare conglomerate's stock worth $1,907,000 after buying an additional 21 shares during the last quarter. Institutional investors and hedge funds own 87.86% of the company's stock.

Insider Activity

In other news, CEO Patrick Hugh Conway sold 589 shares of the company's stock in a transaction dated Tuesday, June 10th. The shares were sold at an average price of $305.00, for a total transaction of $179,645.00. Following the completion of the sale, the chief executive officer owned 10,398 shares of the company's stock, valued at $3,171,390. This represents a 5.36% decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. 0.28% of the stock is currently owned by corporate insiders.

UnitedHealth Group Stock Down 1.5%

Shares of NYSE:UNH opened at $303.77 on Wednesday. The firm has a market capitalization of $275.12 billion, a PE ratio of 13.16, a price-to-earnings-growth ratio of 1.99 and a beta of 0.43. The firm has a fifty day moving average of $289.03 and a 200 day moving average of $393.55. The company has a debt-to-equity ratio of 0.73, a quick ratio of 0.85 and a current ratio of 0.85. UnitedHealth Group Incorporated has a 52-week low of $234.60 and a 52-week high of $630.73.

UnitedHealth Group (NYSE:UNH - Get Free Report) last issued its earnings results on Tuesday, July 29th. The healthcare conglomerate reported $4.08 EPS for the quarter, missing the consensus estimate of $4.45 by ($0.37). UnitedHealth Group had a return on equity of 23.32% and a net margin of 5.04%.The firm had revenue of $111.62 billion during the quarter, compared to analysts' expectations of $111.75 billion. During the same period in the previous year, the firm earned $6.80 earnings per share. The firm's quarterly revenue was up 12.9% compared to the same quarter last year. UnitedHealth Group has set its FY 2025 guidance at 16.000- EPS. As a group, research analysts anticipate that UnitedHealth Group Incorporated will post 29.54 EPS for the current fiscal year.

UnitedHealth Group Announces Dividend

The business also recently declared a quarterly dividend, which will be paid on Tuesday, September 23rd. Stockholders of record on Monday, September 15th will be paid a $2.21 dividend. The ex-dividend date is Monday, September 15th. This represents a $8.84 dividend on an annualized basis and a dividend yield of 2.9%. UnitedHealth Group's payout ratio is currently 38.30%.

Wall Street Analysts Forecast Growth

Several equities analysts recently issued reports on the company. UBS Group restated a "buy" rating on shares of UnitedHealth Group in a research note on Thursday, July 17th. HSBC reaffirmed a "reduce" rating and set a $270.00 target price (down previously from $490.00) on shares of UnitedHealth Group in a report on Wednesday, May 21st. TD Securities reiterated a "hold" rating and issued a $308.00 price objective (down from $520.00) on shares of UnitedHealth Group in a research report on Monday, May 19th. Barclays reaffirmed an "overweight" rating on shares of UnitedHealth Group in a research report on Thursday, July 17th. Finally, Raymond James Financial downgraded UnitedHealth Group from a "strong-buy" rating to a "market perform" rating in a research report on Wednesday, May 14th. Fifteen research analysts have rated the stock with a Buy rating, six have assigned a Hold rating and three have assigned a Sell rating to the stock. According to MarketBeat.com, the company currently has an average rating of "Moderate Buy" and an average target price of $367.71.

About UnitedHealth Group

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.

Want to see what other hedge funds are holding UNH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for UnitedHealth Group Incorporated (NYSE:UNH - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.